PALO ALTO, CA , Oct. 17, 2013 /PRNewswire/ - The PAWS Pet Company , Inc. ( OTCQB PAWS ), is pleased to announce that the three short-term convertible notes that were negotiated with Asher Enterprises, Inc. in 2012 have been paid in full. The final interest payment on the last of those notes was paid today.
The Company is also taking steps to settle most of the remaining debt on its books as part of its ongoing process of moving from the pet space to the pharmaceutical space. Management has received positive responses from several of these important stakeholders and hopes to finalize this process soon.
In further news, the Company believes that an agreement with Pharmacy Development Inc. dba MESA Pharmacy ("MESA") is in its final stages. The Company will update shareholders as events warrant.
About The PAWS Pet Company, Inc.
The PAWS Pet Company, Inc. is undergoing a transition from the pet space to the pharmaceutical space. This exciting transition strategy has been developed to take advantage of the changes underway in traditional medical services. PAWS believes that great opportunities exist in pharmaceuticals and how they are delivered to the public.
For more information on The PAWS Pet Company go to www.thepawspetcompany.com
Company Contact: ir@thepawspetcompany.com
Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) and, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.
Contact: ir@thepawspetcompany.com
SOURCE The PAWS Pet Company, Inc.
AWS) 
(0)
(0)